Is UHS (Universal Health Services) a Cheap Growing Cash Cow?
UHS is a cheap cash cow with strong EPS growth and buybacks, despite recent drops from acquisitions, policy shifts, and rate risks.
- EPS has grown immensely from $9.16 in 2019 to $23.42 in 2025, supported by a massive share buyback program.
- Benefits from strong demographic tailwinds, including an aging population and growth in key states like Texas and Florida.
- Currently trading near its 52-week low, offering a potential 74.5% upside back to its December high.
- The nearly $1B acquisition of TalkSpace introduces integration uncertainties.
- Vulnerable to regulatory headwinds, including Medicare/Medicaid policy changes and potential lawsuit payouts.
- Rising interest rates could compress margins due to the company's significant debt load.
UHS is a fortune 500 company owning over 300 health facilities, hospitals and behavioral health facilities (these deal with mental health, substance abuse, schizophrenic, etc) across the USA and UK...
The company has grown its revenues and earnings significantly over the previous 5 years, they have grown earnings by 50%... Earnings per share over the past 6 years has grown immensly from $9.16 per share in 2019 to $23.42 in 2025. This has been benefitted by the companies immense share buyback programme, betting itself on future growth.
UHS' balance sheet has remained stable in recent history, debt has grown over the last 5 years, from $4.56 to $5.17B, but this is to be expected after the company has returned massive growth in EPS and revenues. The company continues to hold a cash positon of $100-150M.
The company has several large tailwinds... The aging US population will require more health facilities as they get older. Growing chronic diseases. The company has many facilities in parts of the US where there is expected to be high growth in population and thus demand - Texas, Florida, California, Nevada, although the company has exposure across the country.
UHS is currently hovering around it's 52W low, with a potential 74.5% upside back to it's previous high in December, less than 7 months ago.
Why has the stock price dropped so significantly in 2026? It comes down to a few reasons... The purchase of TalkSpace for almost $1B has created some uncertainties. Changing policies of Medicare and Medicade programs which contribute a significant portion of UHS' revenues. Other regulatory changes, such as those introduced on July 4 2025 - which "attaches work and community service requirements to eligibility for Medicaid benefits". The potential increase of interest rates, the company holds some debt (in order to rapidly grow), therefore will have to pay more interest if the rates rise compressing margins. The outcome of upcoming court cases which can make UHS pay out money, which is something almost every company in healthcare has to deal with.
Reflecting on the risk factors of the company, they are mostly (IMO) short term risks that likely will not affect the longterm profitability of the company.
The company offers dividends, which has stayed at $0.20 per share for a number of years, a 0.57% annual return at current prices. The company focuses on buybacks which have ranged from 4% to 11% from 2019 to 2025, which boost EPS and are a bet on themselves. The company has a large insider ownership of over 16%, the company is very interested in giving back to shareholders.
UHS is a solid hedge against the tech sector and the 'AI bubble', still providing high growth, an exceptional level of buybacks and a stable dividend at a 52 week low and a 75% upside back to previous highs 7 months ago.
Not financial advice.
UHS has been dropping hard since February along with other hospital and skilled nursing stocks: (HCA, THC, ENSG). During this exact same time period health insurance and value based care providers have been ripping: (HUM, UNH, AGL, ALHC).
Yes there was a medicare rate decision in April, but the primary driver for both of these trends is decreased healthcare utilization. HCA, HUM and others touched on this trend in their recent earnings call, but its not just first quarter. Check ALHC's recent presentation at Goldman investor conference. They say utilization in second quarter has been benign. Goldman backs them up and says their internal data indicates the same.
The trend of increased health utilization following the early COVID years (maybe 2023-25) appears to have reversed. I've been long and continue to be long AGL, ALHC, ASTH. And I am avoiding hospitals and skilled nursing for the time being.
Interesting opinion, thanks for the insight. I'm always interested in stocks that drop significiantly in such a short period of time without too much reason for the drop... Especially if they have solid fundamentals. Perhaps this is a 'cold' period for hospitals and skilled nursing could recover as quickly as it has gone 'cold'. In the meantime, it makes the companies buybacks even more affective with a lower share price.
I think that this is probably a one time blip. An aging population is going to drive demand for healthcare.
Eventually but it's going to take a while. Covid reinfections were common until start of 2026 and they cause all kinds of health problems: strokes, heart problems, dementia. Covid wastewater levels have been very low for months now. Dialysis and life insurance back up healthier than expected population narrative: check DVA or GL conference calls and stock prices. They are all reporting lower than expected mortality in 2026. As long as wastewater levels stay low it's bullish for health insurers, dialysis providers and life insurance too. At least for a couple of years until continuously aging population reverses the trend once again.
Hey I'm not an investor but I worked for UHS. They're the closest thing I can think of to an evil company, because they value profits above everything else, including staff and patient safety. I hope this company crumbles. Look it up online, they have a lot of news coverage on this stuff and former staff share stories.

r/valueinvesting